Aillis Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 25

Aillis General Information

Description

Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. The company's platform utilizes a specialized camera to capture images of the pharynx and applies AI technology to analyze the images for signs of infection, enabling healthcare providers to diagnose illnesses efficiently and accurately.

Contact Information

Website
www.aillis.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 28-4 Kanda Higashimatsushita-cho
  • Chiyoda-ku
  • Tokyo, 101-0042
  • Japan
Primary Industry
Diagnostic Equipment
Corporate Office
  • 28-4 Kanda Higashimatsushita-cho
  • Chiyoda-ku
  • Tokyo, 101-0042
  • Japan

Aillis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aillis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC (Series D) 04-Apr-2025 Completed Generating Revenue
9. Later Stage VC 18-Nov-2024 Completed Generating Revenue
8. Debt - General 28-Jun-2024 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC (Series D) 22-Dec-2023 Completed Generating Revenue
5. Grant 07-Dec-2023 Completed Generating Revenue
4. Later Stage VC 29-Jun-2022 Completed Generating Revenue
3. Early Stage VC (Series B) 06-Aug-2020 $15.5M $26.5M Completed Startup
2. Early Stage VC (Series A) 08-May-2019 $11M $11M Completed Startup
To view Aillis’s complete valuation and funding history, request access »

Aillis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B2 preferred
B preferred
A preferred 70,864 $52.82 $52.82 1x $52.82 11.67%
To view Aillis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aillis Patents

Aillis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026058450-A1 Processing device, processing program, processing method, and processing system Pending 13-Sep-2024
WO-2025258556-A1 Processing device, processing program, processing method, and processing system Pending 14-Jun-2024
JP-7843002-B2 Oral condition assessment support system Active 09-Apr-2024
WO-2025216154-A1 Oral condition evaluation support system Pending 09-Apr-2024
WO-2025169500-A1 Processing device, processing program, processing method, and processing system Pending 09-Feb-2024
To view Aillis’s complete patent history, request access »

Aillis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aillis Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hero Innovation Group Corporation Minority
JP Life Next Fund Corporate Venture Capital Minority
TAUNS Laboratories Corporation Minority
Aozora Corporate Investment Corporate Venture Capital Minority
Capital Medica Ventures Corporate Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Aillis FAQs

  • When was Aillis founded?

    Aillis was founded in 2017.

  • Where is Aillis headquartered?

    Aillis is headquartered in Tokyo, Japan.

  • What is the size of Aillis?

    Aillis has 100 total employees.

  • What industry is Aillis in?

    Aillis’s primary industry is Diagnostic Equipment.

  • Is Aillis a private or public company?

    Aillis is a Private company.

  • What is Aillis’s current revenue?

    The current revenue for Aillis is .

  • How much funding has Aillis raised over time?

    Aillis has raised $54.6M.

  • Who are Aillis’s investors?

    Hero Innovation Group, JP Life Next Fund, TAUNS Laboratories, Aozora Corporate Investment, and Capital Medica Ventures are 5 of 25 investors who have invested in Aillis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process